Madrigal Pharmaceuticals Inc (MDGL)

Other Income/Expenses (Net)

-$2.48M

TTM · Period ending: · USD

MDGL logo

MDGL Other Income/Expenses (Net)

Latest reported-$2.48M
MDGL Other Income/Expenses (Net) ($0.00 → -$2.48M)
High-resolution chart · PNG

MDGL other income/expenses (net) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Madrigal Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
11,813,000
31,983,000
6,866,000
-1,779,000
636,000
4,076,000
11,024,000
7,645,000
732,000
-1,406,217
-3,673,931
-2,210,000
-2,633,000
-1,702,000
-1,948,000
-569,000
-1,452,000
1,090,000
2,720,999
1,881,000
2,317,000
-588,000
416,000
-18,088,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.